Fig. 8From: An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countriesMedian duration between steps in the Canadian drug access pathway. *PEI was excluded from the average provincial median timeline calculation because the timeline for PEI was only based on 2 drugs being reimbursedBack to article page